Endocrine News Ep - Severe Hypoglycemia: The Frequently Forgotten Threat

Did you attend the live session during ENDO Online? Please navigate to this course page to complete the evaluation.
This podcast is complementary to the virtual live CME-certified Ancillary Symposium presented at ENDO Online 2020. This educational activity is supported by an independent medical educational grant from Lilly USA, LLC. This ancillary symposium is developed through the Endocrine Society’s Special Programs Committee (SPC).





Target Audience

This activity is intended for endocrinologists and endocrine fellows, primary care physicians, physician’s assistants, nurse practitioners and other healthcare professionals. 

Learning Objectives

Upon completion of this educational activity, learners will be able to: 

  • Better understand risks related to hypoglycemia
  • Decrease the frequency and severity of hypoglycemia as an ADE among patients with T2D on insulin and/ or Sus who are identified as high risk
  • Discuss the role of currently available pipeline methods to lower hypoglycemia risk

Additional Information

Target Audience: 
Clinical researcher
Scientific researcher
Nurse/Nurse practitioner
Physician assistant
Allied health professional
Competency Area: 
Patient Care and Procedural Skills
Medical Knowledge
Topic Area: 
Diabetes and Glucose Metabolism
Level of Outcomes: 
Level 4 (Learning: Competence (Shows How))
Activity summary
Available credit: 
  • 0.50 AMA PRA Category 1 Credits
  • 0.50 CME Certificate of Participation
Course opens: 
Course expires: 

This program featured informative sessions directed by key opinion leaders who will discuss different aspects of diabetes technology from the scientific basis to the clinical integration of diabetes technology and time in range in their day to day practice. A case workshop will follow the educational series where challenging, real clinical cases will be provided to the attendees and attendees will answer the case questions through the Audience Response System (ARS). Following each case, the expert faculty presenters will discuss their approach to the cases. This symposium is certified for 1.5 AMA PRA Category 1 Credits™ and 1.5 ABIM MOC points.


Michael McDermott, MD- Program Chair 
University of Colorado Hospital
Aurora, CO 
Elizabeth Seaquist, MD 
University of Minnesota
Minneapolis, MN
Cecilia Low Wang, MD 
University of Colorado  
Denver, CO



The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. 

The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable. 

The following faculty reported no relevant financial relationships during the content development process for this activity:  

  • Michael McDermott, MDCecilia Low Wang, MD 
The following faculty reported  relevant financial relationships during the content development process for this activity:  
  • Elizabeth Seaquist, MD  Advisory Board Member, Mannkind Corporation, Zucara; Research Investigator, Eli Lilly & Company
The following Special Programs Committee member who planned and reviewed content for this activity reported no relevant financial relationships:  
  •  Beret Ann Casey, MD
The following Special Programs Committee members reported financial relationships: 
  • Andjela T. Drincic, MD: Advisory Board Member, Corcept  
  • Sergio Fazio, MD, PhD: Consultant, Amarin, Amgen, Esperion, AstraZeneca  
  • Angela M. Leung, MD: Speaker,Medical Education Resources, MCE Conferences  
  • Amy Rothberg, MD: Advisor, Rhythm Pharmaceuticals; Spouse, consultant of Merck

The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.  

The following Special Programs Committee members reported no relevant financial relationships: 
  • Katherine Araque, MD; Jenny Blau, MD; Lorena Alarcon-Casas Wright, MD, Neena Natt, MD; Deborah Sellmeyer, MD, Savitha Subramanian, MD;  Soleymani Taraneh, MD; Steven Weitzman, MD 
Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

Click "Start" to complete the meeting evaluation, claim CME, and print a certificate of attendance or certificate of participation.

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Endocrine Society has achieved Accreditation with Commendation.

The Endocrine Society designates this live activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Available Credit

  • 0.50 AMA PRA Category 1 Credits
  • 0.50 CME Certificate of Participation

Did you attend the live session during ENDO Online? Please navigate to this course page to complete the evaluation.